Akebia Therapeutics, Inc. (AKBA)

Akebia Therapeutics Market Cap

Akebia Therapeutics has a market cap or net worth of $286.84 million as of April 25, 2024. Its market cap has increased by 128.19% in one year.

• Market Cap: 286.84M
• Enterprise Value: 287.54M
• 1-Year Change: 128.19%
• Ranking: #3371
• Category: Micro-Cap
• Stock Price: $1.37

Market Cap Chart

Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $286.84M, a decrease of -41.23%. That is a compound annual growth rate of -5.13%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	286.80M	-
Apr 23, 2024	286.80M	0.74%
Apr 22, 2024	284.70M	-
Apr 19, 2024	284.70M	-2.16%
Apr 18, 2024	291.00M	-
Apr 17, 2024	291.00M	-0.72%
Apr 16, 2024	293.10M	0.72%
Apr 15, 2024	291.00M	-4.81%
Apr 12, 2024	305.70M	-4.56%
Apr 11, 2024	320.30M	-1.93%
Apr 10, 2024	326.60M	1.30%
Apr 9, 2024	322.40M	0.66%
Apr 8, 2024	320.30M	2.66%
Apr 5, 2024	312.00M	-1.33%
Apr 4, 2024	316.20M	1.35%
Apr 3, 2024	312.00M	-5.68%
Apr 2, 2024	330.80M	-3.08%
Apr 1, 2024	341.30M	-10.93%
Mar 28, 2024	383.20M	-18.29%
Mar 27, 2024	469.00M	12.01%
Mar 26, 2024	418.70M	-9.51%
Mar 25, 2024	462.70M	1.85%
Mar 22, 2024	454.30M	6.37%
Mar 21, 2024	427.10M	5.15%
Mar 20, 2024	406.20M	6.00%

View and export this data all the way back to 2014. Sign Up Today.

Related Stocks

Company	Market Cap
CorMedix	295.98M
Kamada	295.42M
Acrivon Therapeutics	293.28M
Erasca	292.37M
Renovaro Biosciences	291.63M
Pulmonx	289.22M
Anavex Life Sciences	288.59M
ESSA Pharma	285.34M